Qual é o preço para TetraLogic Pharmaceuticals Corporation (TLOG)

O preço para TetraLogic Pharmaceuticals Corporation (TLOG) é $0.00004

Qual é a capitalização de mercado para TetraLogic Pharmaceuticals Corporation (TLOG)

A capitalização de mercado para TetraLogic Pharmaceuticals Corporation (TLOG) é $979.00

TetraLogic Pharmaceuticals Corporation (TLOG) Desdobramentos de Ações

TetraLogic Pharmaceuticals Corporation operates as a clinical-stage biopharmaceutical firm, concentrating its efforts on identifying and advancing small-molecule treatments for cancer and infectious diseases. The company's development pipeline features two key clinical-stage drug candidates: birinapant and SHAPE. Birinapant, a small molecule, functions as a Second Mitochondrial Activator of Caspases (SMAC) mimetic, promoting programmed cell death, or apoptosis, in compromised cells. SHAPE, another proprietary compound, is a histone deacetylase (HDAC) inhibitor intended for topical administration to address early-stage cutaneous T-cell lymphoma. Furthermore, TetraLogic Pharmaceuticals has a research collaboration with the Walter and Eliza Hall Institute of Medical Research to explore the application of SMAC-mimetics, including birinapant, in treating infectious diseases. Founded in 2001 as Gentara Corporation, the company adopted its current name, TetraLogic Pharmaceuticals Corporation, in January 2006 and maintains its headquarters in Malvern, Pennsylvania.

Ano	Desdobramento	Multiplicador	Multiplicador cumulativo
Não há dados suficientes para as datas fornecidas.

Ano

Desdobramento

Multiplicador

Multiplicador cumulativo

Não há dados suficientes para as datas fornecidas.

Empresa	Número de desdobramentos de ações	Multiplicador cumulativo	País
Vertex Pharmaceuticals Incorporated VRTX.US	1	x2	US
Argenx SE ARGX.US	0	-	NL
Lonza Group AG LONN.SW	0	-	CH
UCB S.A. UCB.BR	0	-	BE
Samsung Biologics Co.,Ltd. 207940.KS	0	-	KR

Empresa

Número de desdobramentos de ações

Multiplicador cumulativo

País